4'-Methoxy-α-pyrrolidinopropiophenone

4'-Methoxy-α-pyrrolidinopropiophenone
Systematic (IUPAC) name
(RS)-1-(4-methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code  ?
PubChem CID 6430836
Chemical data
Formula C14H19NO2 
Mol. mass 233.305 g/mol
SMILES eMolecules & PubChem

4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP) is a stimulant drug. It is structurally related to α-PPP in the same way that PMA is related to amphetamine: a methoxy group has been added to the 4-position on the phenyl ring. MOPPP was sold in Germany as a designer drug in the late 1990s and early 2000s,[1][2][3] along with a number of other pyrrolidinophenone derivatives,[4][5] although it has never achieved the same international popularity as its better-known relations α-PPP and MDPV.

See also

References

  1. ^ Springer, D; Fritschi, G; Maurer, HH (2003). "Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry". Journal of Chromatography B 793 (2): 331–42. doi:10.1016/S1570-0232(03)00334-9. PMID 12906908. 
  2. ^ Springer, D; Staack, RF; Paul, LD; Kraemer, T; Maurer, HH (2003). "Identification of cytochrome P450 enzymes involved in the metabolism of 4'-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes". Xenobiotica 33 (10): 989–98. doi:10.1080/00498250310001602775. PMID 14555336. 
  3. ^ Springer, D; Fritschi, G; Maurer, HH (2003). "Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry". Journal of Chromatography B 796 (2): 253–66. doi:10.1016/j.jchromb.2003.07.008. PMID 14581066. 
  4. ^ Maurer, HH; Kraemer, T; Springer, D; Staack, RF (2004). "Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis". Therapeutic drug monitoring 26 (2): 127–31. doi:10.1097/00007691-200404000-00007. PMID 15228152. 
  5. ^ Staack, RF; Maurer, HH (2005). "Metabolism of designer drugs of abuse". Current drug metabolism 6 (3): 259–74. doi:10.2174/1389200054021825. PMID 15975043.